Newsbenzinga
SAB Biotherapeutics To Present SAB-142 Phase 1 Data In Type 1 Diabetes At EASD Meeting September 28-30
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…